The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.

PubWeight™: 2.63‹?› | Rank: Top 1%

🔗 View Article (PMID 16251902)

Published in Nature on October 26, 2005

Authors

Uttiya Basu1, Jayanta Chaudhuri, Craig Alpert, Shilpee Dutt, Sheila Ranganath, Gang Li, Jason Patrick Schrum, John P Manis, Frederick W Alt

Author Affiliations

1: The Howard Hughes Medical Institute, The Children's Hospital, The CBR Institute for Biomedical Research, and Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.

Articles citing this

Mechanism and regulation of class switch recombination. Annu Rev Immunol (2008) 5.98

MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity (2008) 5.03

MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity (2008) 4.59

The AID/APOBEC family of nucleic acid mutators. Genome Biol (2008) 3.25

Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell (2010) 2.92

Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol (2010) 2.80

Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol (2006) 2.50

Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice. Arthritis Rheum (2011) 2.33

PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc Natl Acad Sci U S A (2005) 2.13

The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell (2011) 1.95

Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc Natl Acad Sci U S A (2006) 1.95

Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med (2008) 1.80

Regulation of class switch recombination and somatic mutation by AID phosphorylation. J Exp Med (2008) 1.78

AID and somatic hypermutation. Adv Immunol (2010) 1.74

Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat Immunol (2009) 1.69

A coming-of-age story: activation-induced cytidine deaminase turns 10. Nat Immunol (2009) 1.68

Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol (2009) 1.64

Activation-induced deaminase, AID, is catalytically active as a monomer on single-stranded DNA. DNA Repair (Amst) (2007) 1.57

VLR-based adaptive immunity. Annu Rev Immunol (2012) 1.56

Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice. Proc Natl Acad Sci U S A (2009) 1.50

Generation and characterization of induced pluripotent stem cells from Aid-deficient mice. PLoS One (2014) 1.43

Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID. J Exp Med (2010) 1.43

APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells. Sci Rep (2012) 1.40

Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J Mol Biol (2013) 1.39

AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity. Nat Struct Mol Biol (2009) 1.31

Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G. Nucleic Acids Res (2012) 1.29

RNA polymerase: the most specific damage recognition protein in cellular responses to DNA damage? Proc Natl Acad Sci U S A (2007) 1.26

Cyclin D3 is selectively required for proliferative expansion of germinal center B cells. Mol Cell Biol (2010) 1.24

Regulation of AID, the B-cell genome mutator. Genes Dev (2013) 1.21

The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nat Immunol (2010) 1.20

Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol (2007) 1.19

MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. Nat Immunol (2013) 1.17

DNA repair in antibody somatic hypermutation. Trends Immunol (2006) 1.17

Impact of phosphorylation and phosphorylation-null mutants on the activity and deamination specificity of activation-induced cytidine deaminase. J Biol Chem (2008) 1.16

The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination. Mol Cell Biol (2006) 1.15

Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair. Adv Immunol (2014) 1.11

Regulation of Aicda expression and AID activity. Autoimmunity (2013) 1.11

AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res (2009) 1.09

AID associates with single-stranded DNA with high affinity and a long complex half-life in a sequence-independent manner. Mol Cell Biol (2006) 1.09

Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-kappaB. J Exp Med (2007) 1.06

AID recruits UNG and Msh2 to Ig switch regions dependent upon the AID C terminus [corrected]. J Immunol (2011) 1.06

V-region mutation in vitro, in vivo, and in silico reveal the importance of the enzymatic properties of AID and the sequence environment. Proc Natl Acad Sci U S A (2009) 1.05

Evolution of phosphorylation-dependent regulation of activation-induced cytidine deaminase. Mol Cell (2008) 1.05

Cytoplasmic activation-induced cytidine deaminase (AID) exists in stoichiometric complex with translation elongation factor 1α (eEF1A). Proc Natl Acad Sci U S A (2011) 1.03

GANP-mediated recruitment of activation-induced cytidine deaminase to cell nuclei and to immunoglobulin variable region DNA. J Biol Chem (2010) 1.02

Single-stranded DNA structure and positional context of the target cytidine determine the enzymatic efficiency of AID. Mol Cell Biol (2007) 1.01

A DNA break- and phosphorylation-dependent positive feedback loop promotes immunoglobulin class-switch recombination. Nat Immunol (2013) 1.01

Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation. Proc Natl Acad Sci U S A (2011) 0.99

Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus. J Immunol (2009) 0.99

Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes. Immunology (2009) 0.98

Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein. J Biol Chem (2011) 0.98

Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G. Philos Trans R Soc Lond B Biol Sci (2009) 0.95

Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA. PLoS One (2011) 0.93

Activation-induced cytidine deaminase in antibody diversification and chromosome translocation. Adv Cancer Res (2012) 0.92

Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation. Mol Cell Biol (2010) 0.92

Temporal regulation of Ig gene diversification revealed by single-cell imaging. J Immunol (2009) 0.91

Related Mechanisms of Antibody Somatic Hypermutation and Class Switch Recombination. Microbiol Spectr (2015) 0.90

AID/APOBEC deaminases and cancer. Oncoscience (2015) 0.89

Combinatorial mechanisms regulating AID-dependent DNA deamination: interacting proteins and post-translational modifications. Semin Immunol (2012) 0.89

Hypermutation at A/T sites during G.U mismatch repair in vitro by human B-cell lysates. J Biol Chem (2008) 0.88

AID and APOBECs span the gap between innate and adaptive immunity. Front Microbiol (2014) 0.87

GANP regulates recruitment of AID to immunoglobulin variable regions by modulating transcription and nucleosome occupancy. Nat Commun (2013) 0.86

AIDing Chromatin and Transcription-Coupled Orchestration of Immunoglobulin Class-Switch Recombination. Front Immunol (2014) 0.85

Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers. Immune Netw (2012) 0.85

Expression of AID transgene is regulated in activated B cells but not in resting B cells and kidney. Mol Immunol (2007) 0.85

MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals. J Immunol (2015) 0.84

Cell Cycle Regulates Nuclear Stability of AID and Determines the Cellular Response to AID. PLoS Genet (2015) 0.84

The mechanisms regulating the subcellular localization of AID. Nucleus (2010) 0.84

Evaluation of molecular models for the affinity maturation of antibodies: roles of cytosine deamination by AID and DNA repair. Chem Rev (2006) 0.83

Activation-induced deaminase-mediated class switch recombination is blocked by anti-IgM signaling in a phosphatidylinositol 3-kinase-dependent fashion. Mol Immunol (2007) 0.83

Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat Rev Immunol (2016) 0.82

Cyclin-dependent kinases regulate Ig class switching by controlling access of AID to the switch region. J Immunol (2015) 0.82

Two forms of activation-induced cytidine deaminase differing in their ability to bind agarose. PLoS One (2010) 0.81

Generation and repair of AID-initiated DNA lesions in B lymphocytes. Front Med (2014) 0.81

Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells. MBio (2011) 0.81

Women, autoimmunity, and cancer: a dangerous liaison between estrogen and activation-induced deaminase? J Exp Med (2009) 0.80

Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia. Eur J Immunol (2014) 0.80

Regulation of activation-induced cytidine deaminase DNA deamination activity in B-cells by Ser38 phosphorylation. Biochem Soc Trans (2009) 0.79

Post-translational regulation of activation-induced cytidine deaminase. Philos Trans R Soc Lond B Biol Sci (2009) 0.79

Transcriptional stalling in B-lymphocytes: a mechanism for antibody diversification and maintenance of genomic integrity. Transcription (2013) 0.79

The interaction between AID and CIB1 is nonessential for antibody gene diversification by gene conversion or class switch recombination. PLoS One (2010) 0.79

Immunoglobulin class switch recombination: study through human natural mutants. Philos Trans R Soc Lond B Biol Sci (2009) 0.79

Binding of AID to DNA does not correlate with mutator activity. J Immunol (2014) 0.78

Germinal Center Hypoxia Potentiates Immunoglobulin Class Switch Recombination. J Immunol (2016) 0.78

Replacement of Igamma3 germ-line promoter by Igamma1 inhibits class-switch recombination to IgG3. Proc Natl Acad Sci U S A (2007) 0.77

Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1. Proc Natl Acad Sci U S A (2012) 0.77

Induction of homologous recombination between sequence repeats by the activation induced cytidine deaminase (AID) protein. Elife (2014) 0.76

Lysine residue at position 22 of the AID protein regulates its class switch activity. PLoS One (2012) 0.76

Parp3 negatively regulates immunoglobulin class switch recombination. PLoS Genet (2015) 0.76

AID and RPA: PKA makes the connection local. Nat Immunol (2009) 0.76

AID expression increased by TNF-α is associated with class switch recombination of Igα gene in cancers. Cell Mol Immunol (2015) 0.75

Recombinant retroviral production and infection of B cells. J Vis Exp (2011) 0.75

Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro. Sci Rep (2017) 0.75

PARP activation promotes nuclear AID accumulation in lymphoma cells. Oncotarget (2016) 0.75

You break it, you fix it: functions for AID downstream of deamination. Nat Immunol (2013) 0.75

A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket. Front Immunol (2017) 0.75

Splice variants of activation induced deaminase (AID) do not affect the efficiency of class switch recombination in murine CH12F3 cells. PLoS One (2015) 0.75

The Complex Interplay between DNA Injury and Repair in Enzymatically Induced Mutagenesis and DNA Damage in B Lymphocytes. Int J Mol Sci (2017) 0.75

Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy. J Cancer Res Clin Oncol (2015) 0.75

Articles by these authors

A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science (2004) 17.38

Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A (2003) 9.14

Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell (2006) 8.48

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell (2003) 8.11

Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol (2007) 7.97

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J (2007) 7.30

Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell (2005) 7.29

SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell (2006) 6.79

SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature (2010) 6.48

The mechanism and regulation of chromosomal V(D)J recombination. Cell (2002) 6.28

MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell (2006) 6.09

IgH class switching and translocations use a robust non-classical end-joining pathway. Nature (2007) 6.05

SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell (2008) 5.76

SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell (2008) 5.68

DNA repair, genome stability, and aging. Cell (2005) 5.52

A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A (2008) 5.48

Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell (2003) 5.26

Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature (2003) 5.20

Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci U S A (2002) 5.07

A polymer tandem solar cell with 10.6% power conversion efficiency. Nat Commun (2013) 4.48

Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol (2006) 4.32

Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell (2002) 4.29

53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat Immunol (2004) 4.14

Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol (2004) 4.04

Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res (2003) 4.03

Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell (2012) 4.02

Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature (2004) 3.94

Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell (2011) 3.81

H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol Cell (2006) 3.53

Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP. Cell Metab (2009) 3.51

Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev (2010) 3.49

Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev (2008) 3.46

SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev (2007) 3.34

SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell (2011) 3.33

Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell (2012) 3.30

For the bright future-bulk heterojunction polymer solar cells with power conversion efficiency of 7.4%. Adv Mater (2010) 3.24

The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat Immunol (2011) 3.21

Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab (2005) 3.15

Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology (2004) 3.14

Osteopontin expression correlates with melanoma invasion. J Invest Dermatol (2005) 3.13

SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev (2006) 3.12

Activating Notch1 mutations in mouse models of T-ALL. Blood (2005) 3.08

Mechanism and control of class-switch recombination. Trends Immunol (2002) 2.95

Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Adv Immunol (2007) 2.94

Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature (2003) 2.92

Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair. Mol Cell (2007) 2.88

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med (2007) 2.86

Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol (2008) 2.85

Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest (2009) 2.82

SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab (2010) 2.77

Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev (2008) 2.74

Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Genome Res (2011) 2.73

Calorie restriction alters mitochondrial protein acetylation. Aging Cell (2009) 2.73

The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev (2003) 2.72

The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst) (2004) 2.72

CTCF-binding elements mediate control of V(D)J recombination. Nature (2011) 2.62

Four novel frameworks built by imidazole-based dicarboxylate ligands: hydro(solvo)thermal synthesis, crystal structures, and properties. Inorg Chem (2010) 2.60

A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med (2012) 2.53

Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell (2002) 2.49

Antibody class switching mediated by yeast endonuclease-generated DNA breaks. Science (2006) 2.49

The role of the non-homologous end-joining pathway in lymphocyte development. Immunol Rev (2004) 2.44

Control of sister chromatid recombination by histone H2AX. Mol Cell (2004) 2.43

Deletion of a conserved Il4 silencer impairs T helper type 1-mediated immunity. Nat Immunol (2004) 2.38

The influence of transcriptional orientation on endogenous switch region function. Nat Immunol (2003) 2.38

Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial. Circulation (2012) 2.37

Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med (2003) 2.36

Planar heterojunction perovskite solar cells via vapor-assisted solution process. J Am Chem Soc (2013) 2.32

Empirical likelihood analysis of the Buckley-James estimator. J Multivar Anal (2008) 2.28

Mechanisms promoting translocations in editing and switching peripheral B cells. Nature (2009) 2.27

Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am J Hum Genet (2011) 2.27

Unraveling V(D)J recombination; insights into gene regulation. Cell (2004) 2.25

Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients. Pancreas (2008) 2.24

Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Adv Immunol (2005) 2.19

Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci U S A (2006) 2.17

H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity. Cell Cycle (2004) 2.16

Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med (2003) 2.15

Androgen receptor signaling regulates DNA repair in prostate cancers. Cancer Discov (2013) 2.15

S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. Immunity (2007) 2.11

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med (2008) 2.10

Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis (2008) 2.09

Checkpoint failure and chromosomal instability without lymphomagenesis in Mre11(ATLD1/ATLD1) mice. Mol Cell (2003) 2.08

53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell (2013) 2.05

Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med (2003) 2.02

Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J Clin Oncol (2005) 2.01

The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci (2005) 2.00

WAVE2 deficiency reveals distinct roles in embryogenesis and Rac-mediated actin-based motility. EMBO J (2003) 1.98

Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J Exp Med (2003) 1.98

An evolutionarily conserved target motif for immunoglobulin class-switch recombination. Nat Immunol (2004) 1.98

Activation of remote meta-C-H bonds assisted by an end-on template. Nature (2012) 1.96

Microbial colonization influences early B-lineage development in the gut lamina propria. Nature (2013) 1.96